BackgroundCheck.run
Search For

Vincent R Capodanno, 55163 Beekman Ln, Millstone, NJ 08844

Known as:
Vince R Capodanno
Related to:
Matthew F Capodanno 26 Daniel V Capodanno 24

Vincent Capodanno Phones & Addresses

163 Beekman Ln, Hillsborough, NJ 08844    908-9040833   

Three Bridges, NJ   

Plainsboro, NJ   

Neshanic Sta, NJ   

Bloomsburg, PA   

163 Beekman Ln, Hillsborough, NJ 08844    908-6929292   

Social networks

Vincent R Capodanno

Linkedin

Work

Company: New jersey institute of technology Jan 2019 Position: Statistics data science and machine learning

Education

School / High School: Seton Hall University 2002 to 2005 Specialities: Organic Chemistry

Skills

Pharmaceutical Industry • R&D • Validation • Biotechnology • Cross Functional Team Leadership • Commercialization • Quality By Design • Process Engineering • Vaccines • Project Management • Chemical Engineering • Manufacturing • Pilot Plant • Gmp • Technology Transfer • Research and Development • People Development • Supply Chain Management • Product Launch • Capital Projects • Knowledge Management • Polymorphism • Due Diligence • People Management • Organizational Leadership

Industries

Pharmaceuticals
Get Report
Control this profile

Mentions for Vincent R Capodanno

Vincent Capodanno resumes & CV records

Resumes

Vincent Capodanno Photo 18

Statistics Data Science And Machine Learning

Location:
P/O Box 600, Danville, PA
Industry:
Pharmaceuticals
Work:
New Jersey Institute of Technology
Statistics Data Science and Machine Learning Merck
Head - Chemical Commercialization Technology Merck 2016 - Jan 2018
Director - Chemical Commercialization and Technical Operations Merck 1998 - 2016
Director - Chemical Process Development and Commercialization Merck 2006 - 2008
Manager - Supply Chain Merck 1998 - 2006
Research Fellow - Chemical Engineering R and D Merck 1995 - 1998
Senior Engineer - Vaccine Engineering Merck 1990 - 1995
Engineer
Education:
Seton Hall University 2002 - 2005
Bucknell University 1986 - 1990
Bachelors, Bachelor of Science, Chemical Engineering
Skills:
Pharmaceutical Industry, R&D, Validation, Biotechnology, Cross Functional Team Leadership, Commercialization, Quality By Design, Process Engineering, Vaccines, Project Management, Chemical Engineering, Manufacturing, Pilot Plant, Gmp, Technology Transfer, Research and Development, People Development, Supply Chain Management, Product Launch, Capital Projects, Knowledge Management, Polymorphism, Due Diligence, People Management, Organizational Leadership

Publications & IP owners

Wikipedia

Vincent Capodanno Photo 19

Vincent Robert Capodanno

Servant of God Vincent Robert Capodanno (February 13, 1929 September 4, 1967) was a United States Navy Roman Catholic chaplain and a posthumous recipient of America's highest ...

Us Patents

Formulations Of Suberoylanilide Hydroxamic Acid And Methods For Producing Same

US Patent:
8288440, Oct 16, 2012
Filed:
Jan 13, 2010
Appl. No.:
12/686812
Inventors:
Jeannie Chow Wong - Chicago IL, US
Aaron S. Cote - West Windsor NJ, US
Erik A. Dienemann - Metuchen NJ, US
Kimberly Gallagher - Green Lane PA, US
Craig Ikeda - Harleysville PA, US
Justin Moser - Collegeville PA, US
Pavol Rajniak - Lansdale PA, US
Robert A. Reed - Line Lexington PA, US
Cindy Starbuck - Branchburg NJ, US
Hsien-Hsin Tung - Edison NJ, US
Qingxi Wang - Ambler PA, US
Benjamin Max Cohen - Cranford NJ, US
Vincent R. Capodanno - Hillsborough NJ, US
Brian Sell - Royersford PA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/19
US Classification:
514575
Abstract:
The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.

Formulations Of Suberoylanilide Hydroxamic Acid And Methods For Producing Same

US Patent:
8450372, May 28, 2013
Filed:
Jan 13, 2010
Appl. No.:
12/686843
Inventors:
Jeannie Chow Wong - Chicago IL, US
Aaron S. Cote - West Windsor NJ, US
Erik A. Dienemann - Metuchen NJ, US
Kimberly Gallagher - Green Lane PA, US
Craig Ikeda - Harleysville PA, US
Justin Moser - Collegeville PA, US
Pavol Rajniak - Lansdale PA, US
Robert A. Reed - Line Lexington PA, US
Cindy Starbuck - Branchburg NJ, US
Hsien-Hsin Tung - Edison NJ, US
Qingxi Wang - Ambler PA, US
Benjamin Max Cohen - Cranford NJ, US
Vincent R. Capodanno - Hillsborough NJ, US
Brian Sell - Royersford PA, US
Thomas A. Miller - Wakefield MA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/19
US Classification:
514575
Abstract:
The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.

Formulations Of Suberoylanilide Hydroxamic Acid And Methods For Producing Same

US Patent:
2008013, Jun 5, 2008
Filed:
May 16, 2006
Appl. No.:
11/663165
Inventors:
Jeannie Chow Wong - Chicago IL, US
Aaron S. Cote - West Windsor NJ, US
Erik A. Dienemann - Metuchen NJ, US
Kimberly Gallagher - Green Lane PA, US
Craig Ikeda - Harleysville PA, US
Justin Moser - Collegeville PA, US
Pavol Rajniak - Lansdale PA, US
Robert A. Reed - Line Lexington PA, US
Cindy Starbuck - Branchburg NJ, US
Hsien-Hsin Tung - Edison NJ, US
Qingxi Wang - Ambler PA, US
Benjamin Max Cohen - Cranford NJ, US
Vincent R. Capodanno - Hillsborough NJ, US
Brian Sell - Royersford PA, US
Thomas A. Miller - Brookline MA, US
International Classification:
A61K 31/185
A61P 35/00
US Classification:
514575
Abstract:
The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.

Formulations Of Suberoylanilide Hydroxamic Acid And Methods For Producing Same

US Patent:
2010011, May 6, 2010
Filed:
Jan 13, 2010
Appl. No.:
12/686830
Inventors:
Aaron S. Cote - West Windsor NJ, US
Erik A. Dienemann - Metuchen NJ, US
Hsien-Hsin Tung - Edison NJ, US
Benjamin Max Cohen - Cranford NJ, US
Vincent R. Capodanno - Hillsborough NJ, US
Thomas A. Miller - Brookline MA, US
International Classification:
C07C 233/01
US Classification:
564155
Abstract:
The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.

Crystalline Forms Of A Factor Xa Inhibitor

US Patent:
2012007, Mar 22, 2012
Filed:
Aug 31, 2011
Appl. No.:
13/223023
Inventors:
Vincent R. Capodanno - Rahway NJ, US
Liam Corcoran - Clonmel, IE
Michael McNevin - Summit NJ, US
Itzia Zoraida Arroyo - Rahway NJ, US
Robert M. Wenslow - Rahway NJ, US
Richard G. Ball - Rahway NJ, US
Eric L. Margelefsky - Rahway NJ, US
Timothy K. Maher - Rahway NJ, US
Anjali Pandey - Fremont CA, US
International Classification:
A61K 31/44
A61P 7/02
A61P 9/10
C07D 213/75
US Classification:
514352, 546309
Abstract:
Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof.

Methods And Formulations Of Treating Thrombosis With Betrixaban And A P-Glycoprotein Inhibitor

US Patent:
2014032, Oct 30, 2014
Filed:
Nov 12, 2013
Appl. No.:
14/078415
Inventors:
- S. San Francisco CA, US
George A. Mansoor - Rahway NJ, US
Anne Hermanowski Vosatka - Rahway NJ, US
Vincent R. Capodanno - Rahway NJ, US
Robert M. Wenslow - Rahway NJ, US
Richard G. Ball - Rahway NJ, US
Timothy K. Maher - Rahway NJ, US
Itzia Zoraida Arroyo - Rahway NJ, US
Brett Lauring - Rahway NJ, US
Liam Corcoran - Tipperary, IE
William Denney - Lansdale PA, US
Michael McNevin - Summit NJ, US
Anjali Pandey - Fremont CA, US
Assignee:
Portola Pharmaceuticals, Inc. - S. San Francisco CA
International Classification:
A61K 31/44
A61K 31/343
A61K 31/496
A61K 31/277
US Classification:
51425407, 514353
Abstract:
This invention is directed to methods of inhibiting coagulation or treating thrombosis using a factor Xa inhibitor and a P-glycoprotein (Pgp) inhibitor. The invention is also directed to formulations used in the methods.

Possible Relatives

David M Capodanno  Dawn Capodanno  Joan F Capodanno  Joanne M Capodanno  Karin L Capodanno  Marie A Capodanno  Paul C Capodanno  Vincent R Stanbro  Vincent Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.